215 related articles for article (PubMed ID: 34400351)
1. Vorinostat in autophagic cell death: A critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention.
Patra S; Praharaj PP; Klionsky DJ; Bhutia SK
Drug Discov Today; 2022 Jan; 27(1):269-279. PubMed ID: 34400351
[TBL] [Abstract][Full Text] [Related]
2. Targeting SIRT1-regulated autophagic cell death as a novel therapeutic avenue for cancer prevention.
Patra S; Praharaj PP; Singh A; Bhutia SK
Drug Discov Today; 2023 Sep; 28(9):103692. PubMed ID: 37379905
[TBL] [Abstract][Full Text] [Related]
3. Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma.
Körholz K; Ridinger J; Krunic D; Najafi S; Gerloff XF; Frese K; Meder B; Peterziel H; Vega-Rubin-de-Celis S; Witt O; Oehme I
Cells; 2021 Apr; 10(5):. PubMed ID: 33923163
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.
Shulak L; Beljanski V; Chiang C; Dutta SM; Van Grevenynghe J; Belgnaoui SM; Nguyên TL; Di Lenardo T; Semmes OJ; Lin R; Hiscott J
J Virol; 2014 Mar; 88(5):2927-40. PubMed ID: 24371063
[TBL] [Abstract][Full Text] [Related]
5. Curbing autophagy and histone deacetylases to kill cancer cells.
Gammoh N; Marks PA; Jiang X
Autophagy; 2012 Oct; 8(10):1521-2. PubMed ID: 22894919
[TBL] [Abstract][Full Text] [Related]
6. Importance of TFEB acetylation in control of its transcriptional activity and lysosomal function in response to histone deacetylase inhibitors.
Zhang J; Wang J; Zhou Z; Park JE; Wang L; Wu S; Sun X; Lu L; Wang T; Lin Q; Sze SK; Huang D; Shen HM
Autophagy; 2018; 14(6):1043-1059. PubMed ID: 30059277
[TBL] [Abstract][Full Text] [Related]
7. A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy.
Allavena G; Debellis D; Marotta R; Joshi CS; Mysorekar IU; Grimaldi B
Cell Death Dis; 2018 Jul; 9(7):780. PubMed ID: 30006504
[TBL] [Abstract][Full Text] [Related]
8. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
9. Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.
Banerjee NS; Moore DW; Broker TR; Chow LT
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11138-E11147. PubMed ID: 30385631
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells.
Lee YJ; Won AJ; Lee J; Jung JH; Yoon S; Lee BM; Kim HS
Int J Med Sci; 2012; 9(10):881-93. PubMed ID: 23155362
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
Rivera-Del Valle N; Cheng T; Irwin ME; Donnella H; Singh MM; Chandra J
Cancer Chemother Pharmacol; 2018 Mar; 81(3):483-495. PubMed ID: 29313067
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of novel histone deacetylase inhibitors that inhibit autophagy and induce apoptosis.
Mo H; Zhang R; Chen Y; Li S; Wang Y; Zou W; Lin Q; Zhao DG; Du Y; Zhang K; Ma YY
Eur J Med Chem; 2022 Dec; 243():114705. PubMed ID: 36215854
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells.
Eto S; Saeki K; Yoshitake R; Yoshimoto S; Shinada M; Ikeda N; Kamoto S; Tanaka Y; Kato D; Maeda S; Tsuboi M; Chambers J; Uchida K; Nishimura R; Nakagawa T
PLoS One; 2019; 14(6):e0218382. PubMed ID: 31206526
[TBL] [Abstract][Full Text] [Related]
14. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
15. HDAC inhibition improves autophagic and lysosomal function to prevent loss of subcutaneous fat in a mouse model of Cockayne syndrome.
Majora M; Sondenheimer K; Knechten M; Uthe I; Esser C; Schiavi A; Ventura N; Krutmann J
Sci Transl Med; 2018 Aug; 10(456):. PubMed ID: 30158153
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone deacetylation with vorinostat does not prevent tunicamycin-mediated acute kidney injury.
Carlisle RE; Farooqi S; Zhang MC; Liu S; Lu C; Phan A; Brimble E; Dickhout JG
PLoS One; 2021; 16(11):e0260519. PubMed ID: 34847196
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.
Xie M; Kong Y; Tan W; May H; Battiprolu PK; Pedrozo Z; Wang ZV; Morales C; Luo X; Cho G; Jiang N; Jessen ME; Warner JJ; Lavandero S; Gillette TG; Turer AT; Hill JA
Circulation; 2014 Mar; 129(10):1139-51. PubMed ID: 24396039
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificities.
Newbold A; Matthews GM; Bots M; Cluse LA; Clarke CJ; Banks KM; Cullinane C; Bolden JE; Christiansen AJ; Dickins RA; Miccolo C; Chiocca S; Kral AM; Ozerova ND; Miller TA; Methot JL; Richon VM; Secrist JP; Minucci S; Johnstone RW
Mol Cancer Ther; 2013 Dec; 12(12):2709-21. PubMed ID: 24092806
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors selectively suppress expression of HDAC7.
Dokmanovic M; Perez G; Xu W; Ngo L; Clarke C; Parmigiani RB; Marks PA
Mol Cancer Ther; 2007 Sep; 6(9):2525-34. PubMed ID: 17876049
[TBL] [Abstract][Full Text] [Related]
20. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
